<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mater.</journal-id>
<journal-title>Frontiers in Materials</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mater.</abbrev-journal-title>
<issn pub-type="epub">2296-8016</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">877755</article-id>
<article-id pub-id-type="doi">10.3389/fmats.2022.877755</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Materials</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Functionalized Silicone Elastomer <italic>via</italic> Alkaline Solution to Coat Phosphorylcholine-Based Copolymer Containing Organosilane to Improve Hemocompatibility for Medical Devices</article-title>
<alt-title alt-title-type="left-running-head">Chou et al.</alt-title>
<alt-title alt-title-type="right-running-head">Hemocompatible Polymer on Functionalized Silicone</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chou</surname>
<given-names>Fang-Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hara</surname>
<given-names>Shintaro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uchida</surname>
<given-names>Kazuto</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1683418/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsuo</surname>
<given-names>Youichi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masuda</surname>
<given-names>Tsukuru</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yokoi</surname>
<given-names>Ryo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1683286/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ono</surname>
<given-names>Toshiya</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anraku</surname>
<given-names>Masaki</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Isoyama</surname>
<given-names>Takashi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Takai</surname>
<given-names>Madoka</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/311803/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Bioengineering</institution>, <institution>School of Engineering</institution>, <institution>The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Fuji Systems Corporation</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Biomedical Engineering</institution>, <institution>Graduate School of Medicine</institution>, <institution>The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Thoracic Surgery</institution>, <institution>Graduate School of Medicine</institution>, <institution>The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1523177/overview">Sofia Rangou</ext-link>, Helmhlotz-Zentrum hereon, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1686224/overview">Yang Chen</ext-link>, McMaster University, Canada</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1244989/overview">Wei Ye</ext-link>, Huaiyin Institute of Technology, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Madoka Takai, <email>takai@bis.t.u-tokyo.ac.jp</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Biomaterials, a section of the journal Frontiers in Materials</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>877755</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Chou, Hara, Uchida, Matsuo, Masuda, Yokoi, Ono, Anraku, Isoyama and Takai.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Chou, Hara, Uchida, Matsuo, Masuda, Yokoi, Ono, Anraku, Isoyama and Takai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Surface modification of hemocompatible copolymers on silicone elastomers (SEs) is crucial for the long-term use of medical devices. Both physical adsorption and chemical conjugation are important for modification of SE. Oxygen plasma treatment is widely used to produce silanol groups on SE for silane coupling. However, the plasma reaction is difficult to apply to the surface modification of three-dimensional complex devices. This study demonstrated an appropriate and efficient method with alkaline solution for producing silanol groups on SE for modifying phosphorylcholine-based copolymer with organosilane (cross-MPC copolymer). A 2.5&#xa0;wt% aqueous solution of potassium hydroxide (KOH) was effective in producing silanol groups and for coating the cross-MPC copolymer. Additionally, we successfully modified the cross-MPC copolymer on the inner surface of SE tubes after pretreatment with the 2.5&#xa0;wt% KOH aqueous solution, and the copolymer film was coated homogeneously. The cross-MPC copolymer film on SE was stable for one month under fluidic condition with a shear stress of 3.2&#xa0;Pa. The hollow fiber membrane with the polymer coating inhibited blood coagulation after one week implantation with extracorporeal circulation device using a goat. Therefore, pretreatment of SE using an alkaline solution is an appropriate method for producing silanol groups for coating the cross-MPC copolymer by silane-coupling reaction.</p>
</abstract>
<kwd-group>
<kwd>silicone elastomer</kwd>
<kwd>phosphorylcholine-based copolymer</kwd>
<kwd>surface modification</kwd>
<kwd>alkaline solution</kwd>
<kwd>artificial lung</kwd>
</kwd-group>
<contract-sponsor id="cn001">Japan Agency for Medical Research and Development<named-content content-type="fundref-id">10.13039/100009619</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Artificial organs that are used in contact with blood should be hemocompatible. Specifically, artificial lungs (ALs) with hollow fibers, which have gas exchange functions for removing carbon dioxide and oxygenating blood, are used for treating acute respiratory failure or as a bridge for transplantation in the future (<xref ref-type="bibr" rid="B34">Federspiel et al., 2004</xref>; <xref ref-type="bibr" rid="B11">Iwahashi et al., 2004</xref>; <xref ref-type="bibr" rid="B3">Betit, 2018</xref>). Materials for hollow fibers in membrane-type oxygenators are classified into microporous materials such as polypropylene (PP) (<xref ref-type="bibr" rid="B31">Suma et al., 1981</xref>) and polymethyl pentene (PMP) (<xref ref-type="bibr" rid="B10">Huang et al., 2016</xref>) as well as homogeneous materials such as silicone elastomers (SEs), which have excellent oxygen transparency (<xref ref-type="bibr" rid="B19">Motomura et al., 2003</xref>). The prevention of blood coagulation on the surface of hollow fiber materials is an important strategy to improve their hemocompatibility. There are many reports on the modified surfaces of PP and PMP for clinical oxygenators (<xref ref-type="bibr" rid="B18">Maul et al., 2016</xref>; <xref ref-type="bibr" rid="B23">Ontaneda and Annich, 2018</xref>). Biological molecules such as polypeptides (<xref ref-type="bibr" rid="B37">Zimmermann et al., 2007</xref>; <xref ref-type="bibr" rid="B27">Reser et al., 2012</xref>), heparin (<xref ref-type="bibr" rid="B16">Larm et al., 1983</xref>; <xref ref-type="bibr" rid="B33">Wendel and Ziemer, 1999</xref>; <xref ref-type="bibr" rid="B37">Zimmermann et al., 2007</xref>; <xref ref-type="bibr" rid="B27">Reser et al., 2012</xref>), and albumin (<xref ref-type="bibr" rid="B20">Mulvihill et al., 1990</xref>) have been used as surface modification materials. Given that synthetic polymers are more stable than biological molecule coatings, surface modifications using synthetic polymers such as polyethylene oxide (<xref ref-type="bibr" rid="B8">Eynden et al., 2008</xref>), poly(2-methoxyethyl acrylate) (<xref ref-type="bibr" rid="B30">Suhara et al., 2001</xref>), and phosphorylcholine(PC)-based copolymers (<xref ref-type="bibr" rid="B6">De Somer et al., 2000</xref>; <xref ref-type="bibr" rid="B27">Reser et al., 2012</xref>) have been applied to commercial products (<xref ref-type="bibr" rid="B18">Maul et al., 2016</xref>).</p>
<p>Currently, the usage time of ALs with membrane-type oxygenators is limited to several hours in clinical use due to the poor durability; however, long-term durability is required to apply as a bridge for the transplantation of lungs (<xref ref-type="bibr" rid="B7">Duy Nguyen et al., 2021</xref>). Furthermore, there has been an increasing demand for the continuous use of oxygenators because of the Covid-19 pandemic (<xref ref-type="bibr" rid="B28">Sanford et al., 2020</xref>; <xref ref-type="bibr" rid="B26">Raasveld et al., 2021</xref>), recently.</p>
<p>SE could be a suitable material for long-term use of oxygenators in ALs because of the rejection of plasma leakage caused by homogeneous materials; however, durable surface modification of hemocompatible materials for SE is difficult to obtain. This is mainly because of the hydrophobic recovery of SE (<xref ref-type="bibr" rid="B2">Bausch et al., 1998</xref>). We developed a surface modification method using a PC-based copolymer with organosilane for SE (<xref ref-type="bibr" rid="B21">Nagahashi et al., 2015</xref>). The chemical structure of PC is similar to that of a hydrophilic head group of phospholipids in the outer cell membrane (<xref ref-type="bibr" rid="B38">Zwaal and Hemker, 1982</xref>), and it has non-thrombogenic properties (<xref ref-type="bibr" rid="B25">Pieri et al., 2013</xref>). This PC-based copolymer composed of 2-methacryloyloxyethyl phosphorylcholine (MPC), 3-(methacryloyloxy) propyl-tris(trimethylsilyloxy)silane (MPTSSi), and 3-methacryloxypropyl trimethoxysilane (MPTMSi), denoted as cross-MPC copolymer, exhibited excellent coating stability on SE. The methoxy silane moiety of the MPTMSi unit in the copolymer successfully reacted with the silanol group produced on the silicone surface by oxygen plasma. In addition, the MPTSSi unit, which had good affinity with silicone elastomer, helped the polymer film formation by the hydrophobic interaction with silicone elastomer surface (<xref ref-type="bibr" rid="B29">Seo et al., 2011</xref>; <xref ref-type="bibr" rid="B22">Nii et al., 2013</xref>). The coated cross-MPC copolymer on SE inhibited the adsorption of plasma proteins for three months.</p>
<p>Potassium hydroxide (KOH) solution is widely used as an anisotropic etching reagent for single-crystal silicon (<xref ref-type="bibr" rid="B35">Yun, 2000</xref>), etching of silica glass (<xref ref-type="bibr" rid="B15">Kouassi et al., 2010</xref>; <xref ref-type="bibr" rid="B24">Pfiffer et al., 2017</xref>), and production of a silanol group on the surface (<xref ref-type="bibr" rid="B5">Bruin et al., 1989</xref>). It was reported that SE could be depolymerized by a KOH solution and by cleaving the Si&#x2013;O bond in the main chain (<xref ref-type="bibr" rid="B4">Brook et al., 2012</xref>). Moreover, KOH solution was also used to produce hydroxyl groups on the polymer surfaces, such as silicone-based materials (<xref ref-type="bibr" rid="B36">Zhang et al., 2018</xref>), and poly(vinylidene fluoride) (<xref ref-type="bibr" rid="B1">Al- Gharabli et al., 2017</xref>). In this study, we have applied the liquid-phase process with an alkaline solution for the surface functionalization of silicone elastomer, and evaluated the functions such as hemocompatibility and stability of coated film of the phosphorylcholine-based copolymer containing organosilane. This liquid-phase process has various advantages such as mass production and low cost compared with vacuum-phase processes, such as plasma treatment. Moreover, the durability of the cross-MPC copolymer film on SE was evaluated <italic>in vitro</italic> under dynamic flow condition for one month. The hemocompatibility of the cross-MPC copolymer film-coated hollow fiber membrane as a model of medical devices was tested using a goat blood circuit for a one-week <italic>in vivo</italic> experiment.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Materials</title>
<p>The cross-MPC copolymer was provided by NOF Corporation, Japan, and it was synthesized <italic>via</italic> free radical copolymerization of MPC, MPTSSi, and MPTMSi. The composition ratio of MPC, MPTSSi, and MPTMSi in the cross-MPC copolymer was 54, 27, and 19&#xa0;mol%, respectively (<xref ref-type="bibr" rid="B21">Nagahashi et al., 2015</xref>). This ratio in the cross-MPC copolymer had been optimized to coat polymer film well with good inhibition for protein adsorption, and stability on silicone. Sheets (1.0 &#xd7; 1.0 &#xd7; 0.1&#xa0;cm) and tubes (outer diameter &#x3d; 0.9&#xa0;cm; inner diameter &#x3d; 0.6&#xa0;cm, length &#x3d; 10.0&#xa0;cm) made of SEs were fabricated by Fuji Systems Co. (Tokyo, Japan). The membrane (1.0 &#xd7; 1.0&#xa0;cm) was fabricated from hollow fibers with an outer diameter of 0.4&#xa0;mm, by holding hollow fibers at a constant spacing of 0.4&#xa0;mm using a string.</p>
<p>Rhodamine 6G (R6G), 3-aminopropyltrimethoxysilane (APTES), KOH, sodium hydroxide (NaOH), and sodium dodecyl sulfate (SDS) were purchased from FUJIFILM Wako Pure Chemical Corporation Ltd. (Osaka, Japan). Methanol, ethanol, acetic acid, and phosphate-buffered saline (PBS) were purchased from Kanto Chemical Co., Inc. (Tokyo, Japan). Human serum albumin (HSA), human plasma fibrinogen (HPF), fluorescein isothiocyanate-labeled BSA (FITC-BSA), and glutaraldehyde (GA) were purchased from Sigma&#x2013;Aldrich (St. Louis, MO, United States). The &#xb5;-BCA protein assay kit was purchased from Thermo Fisher Scientific Inc. (Waltham, MA, United States). The blood collection tube with 0.2&#xa0;ml 3.2% citric acid for preparing platelet-rich plasma was purchased from Nipro Corporation (Osaka, Japan).</p>
</sec>
<sec id="s2-2">
<title>Alkaline Pretreatment and Oxygen Plasma Pretreatment on SE</title>
<p>The coating process of the crosslinking-type MPC-copolymer <italic>via</italic> pretreatment of its chemical structure are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. The SE substrates were ultrasonically washed in ethanol for 15&#xa0;min, followed by drying through air blowing. Subsequently, the substrates were immersed in an aqueous solution of NaOH or KOH for 1&#xa0;h with gently shaking on shaker under different conditions, such as the type, concentration, and temperature (<xref ref-type="table" rid="T1">Table 1</xref>). For oxygen plasma treatment, substrates were treated under the condition of 20&#xa0;W at 600&#xa0;mTorr for 2&#xa0;min (PDC-001, Harrick Plasma, NY, United States). Thereafter, the substrates were washed sufficiently with pure water.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic coating procedure for the cross-MPC copolymer film on silicone elastomer (SE) surface <bold>(A)</bold>; Chemical structure of the cross-MPC-copolymer <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fmats-09-877755-g001.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Alkaline pretreatment conditions on silicone elastomers for cross-MPC copolymer coating.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Sample Name</th>
<th align="center">Solute</th>
<th align="center">Concentration</th>
<th align="center">Temperature</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">0.5K</td>
<td align="left">KOH</td>
<td align="center">0.5&#xa0;wt%</td>
<td align="left">Room temperature<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">1.0K</td>
<td align="left">KOH</td>
<td align="center">1.0&#xa0;wt%</td>
<td align="left">Room temperature<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">2.5K</td>
<td align="left">KOH</td>
<td align="center">2.5&#xa0;wt%</td>
<td align="left">Room temperature<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">5K</td>
<td align="left">KOH</td>
<td align="center">5.0&#xa0;wt%</td>
<td align="left">Room temperature<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">2.5N</td>
<td align="left">NaOH</td>
<td align="center">2.5&#xa0;wt%</td>
<td align="left">Room temperature<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">2.5K-45</td>
<td align="left">KOH</td>
<td align="center">2.5&#xa0;wt%</td>
<td align="left">45&#xb0;C</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>The room temperature was around 25&#xb0;C.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-3">
<title>Modification of the Cross-MPC Copolymer by Dip Coating</title>
<p>A methanol solution containing 0.1&#xa0;wt% polymer was mixed with an aqueous solution of 0.1&#xa0;M acetic acid (acetic acid/polymer solution: 10/90, v/v) to prepare a coating solution. The sheets and hollow fibers were coated with the cross-MPC copolymer film by dipping in the coating solution for 2&#xa0;h. To coat the inner surface of the tube with the cross-MPC copolymer, the tubes were filled with the polymer and were sealed with forceps. Thereafter, the sheets, hollow fibers, and tubes were dried in a vacuum chamber for 1&#xa0;h, and then heated at 70&#xb0;C for 3&#xa0;h to dehydrate.</p>
</sec>
<sec id="s2-4">
<title>Evaluating the Formation of the Cross-MPC Copolymer Film on SE</title>
<p>To evaluate the uniformity and thickness of the cross-MPC copolymer film <italic>via</italic> fluorescence microscopy, R6G was stained on the polymer film (<xref ref-type="bibr" rid="B32">Wang et al., 2005</xref>). First, the cross-MPC copolymer-coated SE sheets were immersed in water for 1&#xa0;h, and then they were soaked in an aqueous solution of 0.01&#xa0;wt% R6G at room temperature for 30&#xa0;s. Finally, they were immersed in water for 30&#xa0;min to wash the extra R6G. The sheets were observed <italic>via</italic> fluorescence microscopy (Axioscope 2 Plus, Carl Zeiss AG, Oberkochen, Germany, 10X objective lens, exposure time: 1/30&#xa0;s). The fluorescence images were captured using a charge-coupled device (CCD) camera (VB-7010, Keyence Co., Osaka, Japan), and fluorescence intensity was analyzed using an imaging software (ImageJ, Wayne Rasband). The surface morphology of the cross-MPC copolymer-coated sheets was observed <italic>via</italic> scanning electron microscopy (SEM) at an acceleration voltage of 5&#xa0;kV (JSM-7000Fm, JEOL Ltd. Japan). The cross-MPC copolymer film was coated with osmium (Neoc-ST, MEIWAFOSIS Co. Japan) before the SEM observation.</p>
</sec>
<sec id="s2-5">
<title>Surface Characterization <italic>via</italic> X-Ray Photoelectron Spectroscopy</title>
<p>The elemental composition for evaluating the film stability and silanol groups was characterized <italic>via</italic> XPS (JPS-9010MC, JEOL, Tokyo, Japan). Elemental analysis of poly-SE surfaces was conducted <italic>via</italic> XPS equipped with a 10&#xa0;kV magnesium K&#x3b1; radiation source at an electron take-off angle of 90&#xb0; from the surface.</p>
</sec>
<sec id="s2-6">
<title>Evaluation of Protein Adsorption on the Cross-MPC Copolymer-Coated SE</title>
<p>The amount of adsorbed protein on the cross-MPC copolymer-coated SE surfaces was evaluated <italic>via</italic> the analysis of relative fluorescence intensity (RFI) of the adsorbed FITC-BSA and quantification analysis of the adsorbed BSA using the micro-BCA assay kit. The SE sheets (1.0 &#xd7; 1.0 &#xd7; 0.1&#xa0;cm) were incubated in 4.5&#xa0;mg/ml BSA solution (FITC-BSA: BSA &#x3d; 1 : 9) in PBS at 37&#xb0;C for 1&#xa0;h. Thereafter, the sheets were washed with PBS, and the fluorescence intensity was measured using a fluorescence microscope (Axioscope 2 Plus, Carl Zeiss AG, Oberkochen, Germany, 10X objective lens, exposure time: 1/2&#xa0;s) and analyzed using ImageJ. RFI was calculated according to <xref ref-type="disp-formula" rid="e1">Eq. 1</xref>, where <italic>FI</italic>
<sub>
<italic>poly-SE</italic>
</sub> is the fluorescence intensity of the cross-MPC copolymer-coated SE and <italic>FI</italic>
<sub>
<italic>SE</italic>
</sub> is the fluorescence intensity of SE without polymer coating.<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mi>F</mml:mi>
<mml:mi>I</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mo>%</mml:mo>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:msub>
<mml:mi>I</mml:mi>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>y</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>E</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>F</mml:mi>
<mml:msub>
<mml:mi>I</mml:mi>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>E</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>Eq .(1)</label>
</disp-formula>
</p>
<p>To quantify the adsorbed HSA and HPF, the SE sheets (1.0 &#xd7; 4.0 &#xd7; 0.1&#xa0;cm) were incubated in 0.3&#xa0;mg/ml HSA and 0.3&#xa0;mg/ml HPF at 37&#xb0;C for 1&#xa0;h. The HSA and HPF adsorbed sheets were washed with PBS under magnetic stirring to remove the unabsorbed protein. Then the 3 pieces of protein adsorbed sheets were immersed in 6&#xa0;ml of PBS containing 1&#xa0;wt% SDS. Thereafter, ultrasonic waves were applied at room temperature for 5&#xa0;min to detach the adsorbed HSA and HPF. The concentration of HSA and HPF in the SDS solution was determined using the &#xb5;-BCA protein assay.</p>
</sec>
<sec id="s2-7">
<title>Evaluating the Stability of the Cross-MPC Copolymer Film Under Fluidic Condition</title>
<p>The circulation system for evaluating the stability of the cross-MPC copolymer film under fluidic conditions is illustrated in <xref ref-type="fig" rid="F2">Figure 2</xref>. <xref ref-type="fig" rid="F2">Figure 2A</xref> shows the details of the test module used for the SE sheets. The wall shear stress (WSS) on the sheet was calculated using computational fluid dynamics (CFD) analysis software (ANSYS CFX, Ansys Inc., United States). First, a 3D model of the fluid-contacting surface was established using a computer-aided design (CAD) software (Creo 5.0, Parametric Technology Corporation, United States), as shown in <xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>. Prior to running the CFD analysis, the 3D model was segmented into tetrahedrons. The grid/mesh was fabricated using 1.3 &#xd7; 10<sup>7</sup> elements (surface of tetrahedral structure) and 2.3 &#xd7; 10<sup>6</sup> nodes (grid points of the element corner). As the parameters of the circulating fluid, the density and dynamic viscosity of PBS were set to 1723&#xa0;kg/m<sup>3</sup> and 0.8882&#xa0;mPa s, respectively. The pressure of the outlet was 0&#xa0;mmHg and the flow rate of the inlet was set to 8&#xa0;L/min. The steady state flow was assumed with no-slip condition of the surface and non-gravity effects, and it was set as laminar flow because the Reynolds number was 3659 lower than 4000.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Schematic circulating system for evaluating the stability of the polymer film: <bold>(A)</bold> The tubing with three pieces of silicone elastomer (SE) sheets of 1.27 &#xd7; 1.00&#xa0;cm located inside at a distance of 1.00&#xa0;cm. Cross-sectional view of the tubing. <bold>(B)</bold> Illustration of the liquid flow circulation circuit for evaluating the stability of the cross-MPC copolymer film on different pretreated SE sheets, a) oxygen plasma treated-silicone elastomer (OPT-SE), b) 2.5&#xa0;wt% KOH treated silicone elastomer (2.5K-SE), and c) without pretreated silicone elastomer (SE).</p>
</caption>
<graphic xlink:href="fmats-09-877755-g002.tif"/>
</fig>
<p>The SE sheets (1.27 &#xd7; 1.0 &#xd7; 0.1&#xa0;cm) pretreated with 2.5&#xa0;wt% KOH (2.5K-), oxygen plasma treatment (OPT-), as well as those without pretreatment were used, and were coated with cross-MPC copolymer. The SE sheets were fixed into a Tygon&#xae; R3603 laboratory tubing (inner diameter &#x3d; 1/2 in.; outer diameter &#x3d; 5/8 in.; length &#x3d; 9.0&#xa0;cm). Thereafter, 12 pieces of the tubing with the SE sheets were connected in series, and a reservoir made of polyvinyl chloride and centrifugal pump (CAPIOX&#xae; SP, Terumo, Japan) were joined to form a liquid flow circulation circuit. The reservoir was used to remove air in tubes and centrifugal pumps (<xref ref-type="bibr" rid="B4">Brook et al., 2012</xref>). The liquid circulation circuit was filled with PBS and placed in an incubator at 37&#xb0;C. The flow rate was controlled at 8&#xa0;L/min (2500&#xa0;rpm) using a centrifugal pump. PBS was allowed to flow for 7, 14, 21, and 28&#xa0;days, then the SE sheets were rinsed with water and vacuum dried in a desiccator overnight. The atomic ratio of N/C (N in the MPC unit/C in the polymer film and SE) of the surface of the sheets was evaluated <italic>via</italic> XPS.</p>
</sec>
<sec id="s2-8">
<title>Evaluating the Silanol Group on SE</title>
<p>APTES was used for the reaction of the silanol group and the reaction between the cross-MPC-copolymer and the SE pretreated with alkaline was investigated. Additionally, the OPT-SE sheets were modified with APTES as a control. The pretreated SE sheets were dipped into a 0.5% APTES solution (in ethanol) for 1&#xa0;h at room temperature. Thereafter, the APTES-modified sheets were rinsed with ethanol and dried in vacuum overnight in a desiccator. The spectra of C 1s, N 1s, O 1s, and Si 2p states were analyzed <italic>via</italic> XPS, and the atomic ratio of N/Si was calculated from the elemental composition of the SE after APTES modification.</p>
</sec>
<sec id="s2-9">
<title>Evaluation of Platelet Adsorption on the Cross-MPC Copolymer Film Coated on SE</title>
<p>Platelet-rich plasma (PRP) was freshly prepared from the whole blood of a goat (Japan Saanen goat, female, adult). The whole blood (1.8&#xa0;ml) was collected using a syringe and injected into a blood collection tube. Thereafter, it was centrifuged at 184.5 &#xd7; <italic>g</italic> (1000&#xa0;rpm) for 30&#xa0;min in a refrigerated compact centrifuge (himac-CF7D2, Hitachi Ltd. Japan) at 4&#xb0;C. The mixture of plasma supernatant containing platelets and a small amount of red blood cells was transferred into another sterile tube and centrifuged at 1660.2 &#xd7; <italic>g</italic> (3000&#xa0;rpm) for 5&#xa0;min at 4&#xb0;C. The supernatant was used as PRP. The PRP concentration was 1.1&#xd7;10<sup>8</sup> &#xb1; 1.2&#xd7;10<sup>7</sup> cell/mL.</p>
<p>SE were immersed in PBS overnight. Thereafter, SE, and the cross-MPC copolymer-coated SE (poly-2.5K-SE) sheets were incubated in PRP at 37&#xb0;C for 1&#xa0;h. The incubated poly-2.5K-SE, and SE sheets were rinsed with PBS to remove unadhered platelets. The PRP incubation for stability evaluation was same as polymer coated SE. The adhered platelets were fixed with 2.5&#xa0;wt% GA in PBS for 30&#xa0;min at room temperature. All the sheets were immersed in 50, 60, 70, 80, 90, 95% ethanol/water solution, and 100% ethanol for 30&#xa0;min in order. Thereafter, the sheets were dried in a vacuum overnight and stored in a desiccator. The platelets that adhered on the SEs were observed <italic>via</italic> SEM at an acceleration voltage of 5&#xa0;kV (JSM-7000Fm, JEOL Ltd. Japan) after coating with osmium using a plasma coater.</p>
</sec>
<sec id="s2-10">
<title>Evaluation of Hemocompatibility <italic>via In-Vivo</italic> Experiment Using a Goat</title>
<p>The long-term blood compatibility of the hollow fibers made of SE in contact with blood was evaluated <italic>via</italic> an <italic>in-vivo</italic> experiment. <xref ref-type="fig" rid="F3">Figure 3</xref> illustrates the blood circulation system for <italic>the in vivo</italic> experiment using a goat (healthy Japanese Saanen goat, wild type, female, 44.5&#xa0;kg). The blood tests were analyzed before surgery and the results are summarized in <xref ref-type="sec" rid="s11">Supplementary Table S1</xref>. The <italic>in vivo</italic> experiment was performed according to the guidelines of the Animal Experiment Committee at the Graduate School of Medicine, the University of Tokyo. We fabricated a chamber that was pasted on the hollow fiber membrane (HFM) with a size of 1.0 &#xd7; 1.0&#xa0;cm. The membrane was pre-treated at 2.5&#xa0;K (<xref ref-type="table" rid="T1">Table 1</xref>) and coated with the cross-MPC copolymer by dipping it in a of 0.1&#xa0;wt% polymer solution for 1&#xa0;h. Thereafter, it was dried in vacuum for 1&#xa0;h and heated for 3&#xa0;h. Subsequently, the cross-MPC copolymer-coated membrane (poly-HFM) and that not coated (HFM) were fixed on a rectangular acrylic plate. Acrylic plates with 16 pieces of poly-HFM and HFM were then fabricated as chambers, as shown in <xref ref-type="fig" rid="F3">Figure 3A</xref>.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<bold>(A)</bold> Development of a chamber of acrylic plates pasted with membranes made of hollow fibers (HFM) of 1.0 &#xd7; 1.0&#xa0;cm. Eight pieces of HFM were coated with the cross-MPC copolymer (poly-HFM). <bold>(B)</bold> Schematic illustration of <italic>in-vivo</italic> experiment for evaluating the blood compatibility. The chamber was connected to the ECMO system in series. The centrifugal pump in ECMO system was controlled from 1.0 to 2.0&#xa0;L/min.</p>
</caption>
<graphic xlink:href="fmats-09-877755-g003.tif"/>
</fig>
<p>Anesthesia was induced using isoflurane. The pulmonary artery was connected to sutured cannulas of inflow and outflow to the left atrial appendage. An extracorporeal membrane oxygenation (ECMO) system (EMERSAVE, Terumo Corporation) was attached to the sutured cannula for extracorporeal circulation. The chamber was attached by cutting the tube in the circulation system between the centrifugal pump and AL. The blood flow was measured using a flow meter and controlled using a pump controller between 1.0 and 2.0&#xa0;L/min. The activated clotting time (ACT) in the blood was adjusted to less than 250 using heparin. After 1&#xa0;week of circulation, the chamber was removed from the ECMO system. After washing the chamber with PBS, the poly-HFMs and HFMs were fixed with 2.5% GA and observed <italic>via</italic> SEM.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<sec id="s3-1">
<title>Alkaline Pretreatment Conditions for the Cross-MPC Copolymer Coating</title>
<p>OPT is a method for the pretreatment of the surface modification of SE to produce silanol groups. However, the travel length of the active plasma species produced under vacuum is limited by pressure and flow rate. In addition, the active species are eliminated by collision with the surface of the materials. Therefore, OPT is not appropriate for the inner wall surfaces of long tubes and textile hollow fibers (<xref ref-type="bibr" rid="B24">Pfiffer et al., 2017</xref>). Therefore, we focused on a pretreatment method using an alkaline solution without vacuuming and complex operation, which is suitable for the three-dimensional complex-shaped medical devices. Alkaline solutions have reportedly been used for etching (<xref ref-type="bibr" rid="B35">Yun, 2000</xref>) as well as the functionalization of silicon and silicon oxide (<xref ref-type="bibr" rid="B5">Bruin et al., 1989</xref>). In this study, aqueous solutions of KOH and NaOH were used to provide hydroxide ions for alkaline treatment. After pretreatment using the alkaline aqueous solutions under various conditions, the SE sheets were coated with the cross-MPC copolymer (<xref ref-type="table" rid="T1">Table 1</xref>). In the code of treatments, &#x201c;K&#x201d; and &#x201c;N&#x201d; indicate KOH and NaOH, respectively. &#x201c;2.5K&#x201d; indicates that 2.5&#xa0;wt% KOH aqueous solution was used. An SE sheet pretreated with oxygen plasma for 2&#xa0;min was used to compare the effect of oxygen plasma treatment (OPT). Here, &#x201c;poly-&#x201d; indicates that the samples were coated with a polymer. The formation of a polymer film and protein adsorption were evaluated by treatment with R6G and FITC-BSA, respectively. First, we have confirmed the fluorescence intensity of the adsorbed R6G on the cross-MPC copolymer film prepared with different concentrations of polymer solutions (<xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>) and understood that the fluorescence intensity of adsorbed R6G is a good indicator to be determined the film formation. <xref ref-type="fig" rid="F4">Figure 4A</xref> shows the fluorescence intensity of R6G for the polymer film on SE pretreated with different alkaline solution conditions and O<sub>2</sub> plasma. The fluorescence images of R6G for the polymer film on SE pretreated with different alkaline solution conditions and O<sub>2</sub> plasma are shown in <xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>. The results of the fluorescence intensity of adsorbed R6G show that every pretreatment for the polymer coating on SE could form polymer film well. Next, protein adsorption was evaluated by use of FITC-BSA to optimize the parameters for pretreatment, which is one of the factors of blood coagulation. We evaluated the RFI of FITC-BSA absorbed on the coated polymer films under different pretreatment conditions (<xref ref-type="table" rid="T1">Table 1</xref>). The results are shown in <xref ref-type="fig" rid="F4">Figure 4B</xref>. The amount of the protein on the polymer coated with 2.5K-treated SE (poly-2.5K) was lower than those on the polymer coated with 0.5K-treated SE (poly-0.5K), and with 1.0K-treated SE (poly-1.0K). When the temperature was increased to 45&#xb0;C, the adsorbed FITC-BSA significantly increased; therefore, we investigated the influence of pretreatment using an alkaline solution by evaluating the surface morphology. <xref ref-type="fig" rid="F4">Figure 4C</xref> shows the optical microscopic images of SE without treatment (SE), as well as with the 2.5K and 2.5K-45 pretreatments. There were many pits on the surface of the 2.5K-45 pretreatment because the SE was etched by an alkaline solution (<xref ref-type="bibr" rid="B4">Brook et al., 2012</xref>). It has been reported that rough surfaces have more adsorption of proteins (<xref ref-type="bibr" rid="B17">Maeda et al., 2000</xref>); therefore, the etched surface with many pits induced protein adsorption. Moreover, the protein adsorption on the poly-5K was much larger than that on the poly-2.5K. Looking at the polymer-coated with 2.5N-treated SE (poly-2.5N), and polymer-coated with O<sub>2</sub> plasma-treated SE (poly-OPT), the fluorescence intensity of adsorbed FITC-BSA on poly-2.5N was the same of that on poly-2.5K, and that on poly-OPT was smaller than on poly-2.5K. The surface morphology of 2.5N-SE is rough than 2.5K-SE by SEM images shown in <xref ref-type="sec" rid="s11">Supplementary Figure S4</xref>, because NaOH is a stronger etchant than KOH (<xref ref-type="bibr" rid="B12">Jaffer and Weitz, 2019</xref>). Compared with the surface of OPT-SE and 2.5K-SE, the OPT-SE is smoother than 2.5K-SE (<xref ref-type="sec" rid="s11">Supplementary Figure S4</xref>), but the etching by O<sub>2</sub> plasma has occurred more severe than 2.5K. We confirmed that the etching thickness of O<sub>2</sub> plasma was around three times higher than that of KOH solution, although the etching occurred in less than several nanometers. In summary of the alkaline solution pretreatment, the increase in surface roughness was caused by an increase in the concentration of the alkaline solution and the reaction temperature. Hence, the 2.5K alkaline treatment was the most appropriate condition for alkaline treatment and was applied for various experiments.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Characterizations of the polymer film coated under different conditions (<xref ref-type="table" rid="T1">Table 1</xref>). Fluorescence intensity of the adsorbed R6G on the polymer film <bold>(A)</bold>; Relative fluorescence intensity of adsorbed FITC-BSA on the polymer-coated surface. <bold>(B)</bold> Results are presented as mean &#xb1; SD (<italic>n</italic> &#x3d; 9). <bold>(C)</bold> Optical microscope images for surface morphology of SEs (i) without treatment, (ii) treated with 2.5&#xa0;K, (iii) treated with 2.5K&#x2013;45. &#x2a;<sup>,</sup> &#x2a;&#x2a;, and &#x2a;&#x2a;&#x2a; indicate <italic>p</italic> &#x3c; 0.05, <italic>p</italic> &#x3c; 0.01, and <italic>p</italic> &#x3c; 0.001, respectively.</p>
</caption>
<graphic xlink:href="fmats-09-877755-g004.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Evaluation of the Formation of a Polymer Film on the Surface in an SE Tube</title>
<p>Here, the applicability of alkaline solution pretreatment on the inner surface of tubular-shaped materials was evaluated. The inner surfaces of the SE tubes (inner diameter: 0.6&#xa0;cm) were pretreated with 2.5&#xa0;wt% alkaline solution. Thereafter, the pretreated tubes were coated with the polymer. The polymer-coated tubes were cut into small pieces to evaluate the polymer film coating and protein adsorption (<xref ref-type="fig" rid="F5">Figure 5A</xref>). As shown in <xref ref-type="fig" rid="F5">Figure 5B</xref>, the fluorescence intensities of adsorbed R6G at the different parts of the inner tubes were not significantly different, indicating that the polymer-coated film on the alkaline-treated tube was homogeneous.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Characterization of the polymer coated in silicone elastomer tube (inner diameter: 0.6&#xa0;cm). <bold>(A)</bold> Procedure for the characterization of the polymer-coated tubes with an alkaline solution (2.5K). The tubes were cut into small pieces before staining them with Rhodamine 6G (R6G) and FITC-BSA/BSA incubation. Fluorescence intensity of the adsorbed R6G <bold>(B)</bold> and relative fluorescence intensity of the adsorbed FITC-BSA <bold>(C)</bold> on the polymer-coated tube with alkaline pretreatment (2.5&#xa0;K). Results are presented as mean &#xb1; SD (<italic>n</italic> &#x3d; 3).</p>
</caption>
<graphic xlink:href="fmats-09-877755-g005.tif"/>
</fig>
<p>Additionally, protein adsorption was evaluated by measuring the RFI with FITC-BSA/BSA incubation. As shown in <xref ref-type="fig" rid="F5">Figure 5C</xref>, after polymer coating on the alkaline pretreated tube, the entire area in the SE tube prevented protein adsorption with a homogeneous polymer film. These results indicate that pretreatment with an alkaline solution is appropriate for the coating of cross-linked copolymers on tubular-shaped materials or medical devices with complex structures.</p>
</sec>
<sec id="s3-3">
<title>Evaluating the Long-Term Stability of the Cross-MPC Copolymer Film Under Fluidic Conditions</title>
<p>The stability of the coated copolymer film on the SE surface under fluidic conditions is crucial for applications in medical devices, specifically ALs. Thus, we fabricated a circulating system for evaluating the long-term stability of the polymer films on SE, 2.5K-SE, and OPT-SE. Maeda <italic>et. al.</italic> established that the upper limit of the blood flow rate in a silicone oxygenator was 5&#xa0;L/min (<xref ref-type="bibr" rid="B17">Maeda et al., 2000</xref>). Therefore, we set the flow rate for the circulating system to 8&#xa0;L/min, which is high but provides more severe conditions for evaluating the stability of the polymer film. In the circulation system, the sheets were stuck in the tube in series at an interval of 1.0&#xa0;cm (<xref ref-type="fig" rid="F2">Figure 2</xref>). Because it is necessary for each SE sheet in the tube to be tuned under the same WSS, we performed a CFD simulation to confirm the fluidic condition of the evaluation system. As an important parameter that can affect the results, the WSS forced on the sheets was evaluated, and it is shown in <xref ref-type="fig" rid="F6">Figure 6A</xref>. The color map in <xref ref-type="fig" rid="F6">Figure 6Ai</xref> shows that the fluid jet occurred at the corners of the sheets when the fluid hit the sheet owing to the Coand&#xe2; effect. These fluidic jets exhibited high WSS, represented in green-yellow on the sheet. However, <xref ref-type="fig" rid="F6">Figure 6Aii</xref> shows that WSS near the sheet did not have a significant difference and that on the sheets was not affected by the fluidic jets. Additionally, the average value of WSS was 3.2&#xa0;Pa.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Stability evaluation of the coated polymer film on the silicone elastomer (SE) sheet in a fluidic circulating system. <bold>(A)</bold> Color maps for cross section view of side (i) and top view (ii) of wall shear stress (WSS) by computational fluid dynamics (CFD) model in the tubing (inner diameter &#x3d; 1.27&#xa0;cm; outer diameter &#x3d; 1.59&#xa0;cm). The arrows indicate the SE sheets. The inlet flow rate was set as 8&#xa0;L/min without outlet pressure. <bold>(B)</bold> The N/C (nitrogen comes from the polymer/carbon) ratio of the coated-polymer film on oxygen plasma treated (poly-OPT), 2.5&#xa0;K alkaline treated (poly-2.5K), and untreated (poly-SE sheets. The data was measured every week for one month. Results are presented as mean &#xb1; SD (<italic>n</italic> &#x3d; 6). &#x2a;<sup>,</sup> &#x2a;&#x2a;, and &#x2a;&#x2a;&#x2a; denote <italic>p</italic> &#x3c; 0.05, <italic>p</italic> &#x3c; 0.01, and <italic>p</italic> &#x3c; 0.001, respectively. <bold>(C)</bold> Evaluation of the silanol group on the surface of SE. The silanol group was reacted with APTES after treatment with 2.5&#xa0;K (APTES-2.5K) and oxygen plasma (APTES-OPT), and then N/Si (nitrogen comes from APTES/silicon) was measured <italic>via</italic> XPS. Results are presented as mean &#xb1; SD (<italic>n</italic> &#x3d; 3).</p>
</caption>
<graphic xlink:href="fmats-09-877755-g006.tif"/>
</fig>
<p>Thus, the results of the CFD analysis indicated that the evaluation setup composed of the fluidic circulation system shown in <xref ref-type="fig" rid="F2">Figure 2B</xref> was reliable for evaluating the stability of the coated polymer film.</p>
<p>After aging under fluidic condition, the atomic composition of N in the MPC component, C in the SE, and cross-MPC copolymers were analyzed <italic>via</italic> XPS. <xref ref-type="fig" rid="F6">Figure 6B</xref> shows the relationship between the atomic ratio of N/C and the aging time. The remaining polymer films on OPT SE (poly-OPT) and 2.5&#xa0;wt% KOH solution-treated SE (poly-2.5K) at each aging time exhibited a similar decreasing trend. Conversely, the remaining polymer film on the non-treated FSE (poly-SE) significantly decreased after aging for 1 month, and had significant difference from the poly-2.5K. Although the continuous flow was circulated for 4 weeks, the polymer film coated after pretreatment with the alkaline solution and oxygen plasma remained on the SE. Moreover, the N/C ratio for indicating the remaining polymer of poly-OPT and poly-2.5K was slightly decreased owing to the degradation of the polymer.</p>
<p>Because the pretreatment conditions affect the stability of the cross-MPC copolymer coatings, the amount of activated silanol groups on the surface are crucial for maintaining the stability of the coatings. Thus, the modified APTES on the SE surface was analyzed to identify the silanol group that affects the stability of the polymer film on the pretreated SE. In the code of treatments, &#x201c;APTES-OPT&#x201d; and &#x201c;APTES-2.5K&#x2033; indicate APTES-conjugated OPT-SE and APTES-conjugated 2.5&#xa0;K-SE, respectively. The XPS spectrums of Si2p, C1s, O1s, and N1s of APTES-2.5K, APTES-OPT, and SE are shown in <xref ref-type="sec" rid="s11">Supplementary Figure S5</xref>. The N/Si ratio of APTES-2.5K and APTES-OPT increased, as shown in <xref ref-type="fig" rid="F6">Figure 6C</xref>. The treatment using KOH solution and OPT produced silanol groups, which were reacted with APTES. Considering the relationship between the stability of the polymer film and the density of the silanol group, the stability was successfully enhanced by increasing the density of the silanol group. Generally, the 2.5K alkaline treatment obtained sufficient silanol groups on the SE surface to provide conjugatable sites for coating the cross-MPC copolymer.</p>
</sec>
<sec id="s3-4">
<title>Evaluating the Hemocompatibility of the Cross-MPC Copolymer Film Before and After Aging by Fluidic Circulating System</title>
<p>Evaluating hemocompatibility is necessary for the clinical application of biomaterials. Plasma protein adsorption is crucial during the first stage of blood coagulation (<xref ref-type="bibr" rid="B12">Jaffer and Weitz, 2019</xref>). To discuss the optimizing parameters of alkaline treatment, the protein adsorption has been evaluated by RFI of FITC-BSA. Here, the relative amount of adsorption of human serum albumin (HSA) and human plasma fibrinogen (HPF) was used to know the relationship to platelet adhesion, which correlates the hemocompatibility. The adsorbed protein was evaluated by a quantitation method <italic>via</italic> micro-BCA method, and the results were shown in <xref ref-type="fig" rid="F7">Figure 7A</xref>. It indicated that relative HSA adsorption on poly-2.5K and poly-OPT were 71 and 69% of that on SE, and the relative HPF adsorption on poly-2.5K and poly-OPT were 47 and 45% of that on SE. Both poly-2.5K and poly-OPT had an ability to reduce the adsorption of HSA and HPF, respectively. In addition, platelet adhesion and activation affect blood coagulation (<xref ref-type="bibr" rid="B13">Jung et al., 2013</xref>; <xref ref-type="bibr" rid="B9">Gremmel et al., 2016</xref>). The morphology of the adhered platelets on PRP statically-incubated SE, and poly-2.5K-SE surfaces was observed <italic>via</italic> SEM. SEM micrographs of <xref ref-type="fig" rid="F7">Figure 7Bi</xref> at low magnification showed that were many adhered platelets (262 &#xb1; 48 cells/mm<sup>2</sup>) on the surface of the PRP-incubated SE. As shown in <xref ref-type="fig" rid="F7">Figure 7Biii</xref>, the platelets on the SE surface were adhered and activated. Conversely, only a few inactivated platelets were found on the poly-2.5K-SE surface, as shown in <xref ref-type="fig" rid="F7">Figures 7Bii,iv</xref>. These results indicate that the poly-2.5K-SE inhibited protein adsorption and platelet adhesion.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>
<bold>(A)</bold> Relative HSA and HPF adsorption on the uncoated SE, poly-OPT-SE, as well as the poly-2.5K-SE <italic>via</italic> &#xb5;-BCA assay. <bold>(B)</bold> Hemocompatibility evaluation under static condition. SEM micrographs of SE and poly-2.5K-SE after incubation in PRP for 1&#xa0;h at 37&#xb0;C, (i)-(ii) magnified image (500X), (iii)-(iv) magnified image (7,000X). <bold>(C)</bold> Hemocompatibility evaluation after aging under fluidic circulation for 4 weeks. SEM micrographs of (i) SE, (ii) poly-2.5K-SE, (iii) poly-OPT-SE, and (iv) poly-SE after incubation in PRP for 1&#xa0;h at 37&#xb0;C.</p>
</caption>
<graphic xlink:href="fmats-09-877755-g007.tif"/>
</fig>
<p>To confirm the hemocompatibility of the coating film of cross-MPC copolymer after aging under fluidic circulating for 4&#xa0;weeks which are the same condition shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, the SE, poly-OPT-SE, poly-2.5K-SE and poly-SE substrates were incubated in PRP for 1&#xa0;h at 37&#xb0;C, and then observed by SEM. The PRP incubated SE was conducted as control. The SEM images of adhered platelet are shown in <xref ref-type="fig" rid="F7">Figure 7C</xref>. The results indicated that the poly-2.5K and poly-OPT still had good inhibition of platelet adhesion after aging by fluidic circulating with PBS for 4&#xa0;weeks. By contrast, the poly-SE had many adhered platelets on the surface. These results were suggested that high-density of silanol group produced by KOH solution on silicone elastomer improved the stability of polymer film and keep hemocompatibility for long time. Thus, this surface modification can be applied to medical devices for long-term use.</p>
</sec>
<sec id="s3-5">
<title>Evaluation of the Hemocompatibility of Hollow Fiber Membrane <italic>via</italic> One Week <italic>In-Vivo</italic> Implantation</title>
<p>The hemocompatibility of the polymer-coated membrane made of hollow fiber with KOH pretreatment (denoted poly-HFM) was evaluated <italic>via in-vivo</italic> implantation in a goat for one week. Thrombus was observed using the naked eye and <italic>via</italic> SEM. <xref ref-type="fig" rid="F8">Figure 8A</xref> shows a photograph of the chamber, which is burnt red owing to the thrombus on all membranes of HFM without polymer coating. For the polymer-coated HFM, thrombus was observed in some parts. As shown in <xref ref-type="fig" rid="F8">Figure 8Bi</xref>, various blood cells adhered to the poly-HFM surface. However, as shown in <xref ref-type="fig" rid="F8">Figure 8Bii</xref>, a high magnification image showed that the platelets were not activated because the polymer film inhibited the platelet activation. Unlike the polymer-coated hollow fiber, severe blood coagulation was observed on HFM, as shown in <xref ref-type="fig" rid="F8">Figures 8Biii,iv</xref>. Thicker thrombi are induced by the activation of platelets, leading to the formation of the thrombus on the HFM.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>
<bold>(A)</bold> Photograph of the chamber with 16 pieces of membranes made of the hollow fiber (HFMs) after one week of implantation in goat. The upper part of the membranes was coated with the polymer film (poly-HFM), and the lower part was left uncoated. <bold>(B)</bold> The SEM images of the hollow fiber coated with the polymer film (i, ii) and those without polymer coating (iii, iv).</p>
</caption>
<graphic xlink:href="fmats-09-877755-g008.tif"/>
</fig>
<p>This result was consistent with the results of protein adsorption and platelet adhesion in the <italic>in-vitro</italic> evaluation, as shown in <xref ref-type="fig" rid="F7">Figure 7</xref>. The activated platelets on SE contributed to blood coagulation and led to burnt red thrombus, as shown in <xref ref-type="fig" rid="F8">Figure 8A</xref>. In addition, the thrombus filled the space between the hollow fibers (<xref ref-type="fig" rid="F8">Figure 8Biii</xref>) because they formed easily under a slow flow rate. These results implied that the blood did not coagulate on the poly-HFM. The poly-HFM treated with KOH solution exhibited good hemocompatibility for <italic>in-vivo</italic> implantation for one week under fluidic conditions.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>In this study, the cross-MPC copolymer was coated <italic>via</italic> a silane coupling reaction on functionalized SE, which was treated by alkaline solution. The type and concentration of the alkaline solution as well as the reaction temperature were optimized to achieve good polymer film formation and effective inhibition of protein adsorption on the coated polymer films. The increased protein adsorption on the polymer-coated SE was induced by the stronger etching resulting from high concentration and high temperature of KOH and NaOH solutions, which increased the roughness of SE. The 2.5&#xa0;wt% KOH solution at room temperature performed better compared to other pretreatment conditions, as evidenced by less protein adsorption on polymer-coated surface and good polymer film formation. The optimum conditions for alkaline treatment were applied to the coating on the inner surface of the SE tube. There was no difference in the fluorescence intensity in different areas, which indicated excellent homogeneity of the coated polymer film on the SE surface in tube. Although the polymer films were removed gradually under the shear stress (3.2&#xa0;Pa) of the fluid condition, the stability of the cross-MPC copolymer film on the SE pretreatment with 2.5K alkaline solution for one month was comparable to that of the polymer film on SE pretreated with OPT. It was established that the increase in the stability of the cross-MPC copolymer film on SE depended on the amount of the silanol groups. The results of platelet adhesion on 4-weeks aging under fluidic condition shows that the stability of cross-MPC copolymer film on the SE pretreated with 2.5K alkaline solution was good enough to inhibit platelet adhesion. For <italic>in vivo</italic> experiments using a goat with ECMO, the cross-MPC copolymer-coated HFM effectively inhibited blood coagulation for one week under blood flow. In summary, coating film of the cross-MPC copolymer <italic>via</italic> silane coupling reaction on functionalized silicone elastomer by KOH solution could keep good hemocompatibility for long time. This is beneficial for developing improved interfaces for medical devices.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the University of Tokyo Animal Experiment Committee. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>F-YC: conceptualization, methodology, data curation, investigation, visualization, writing&#x2014;original draft; SH: investigation, visualization, writing&#x2014;review &#x26; editing; KU: investigation, validation; YM: investigation, validation; TM: visualization, writing-review &#x26; editing; RY: methodology for chamber with hollow fiber membranes, resources for silicone elastomer substrates; TO: investigation for <italic>in vivo</italic> experiment; MA: supervision, funding acquisition, investigation for surgery of <italic>in vivo</italic> experiment, writing&#x2014;review &#x26; editing; TI: supervision, writing&#x2014;review &#x26; editing; MT: conceptualization, supervision, funding acquisition, writing&#x2014;review &#x26; editing.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by Japan Agency for Medical Research and Development (AMED) (grant number 18hm0102048h0002) (MT, MA, and RY), and Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (grant number 20K17577) (SH). The funds received for open access publication fees from our other grants.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>RY was employed by the company Fuji Systems Corporation.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>A part of this work was conducted at Advanced Characterization Nanotechnology Platform of the University of Tokyo, supported by &#x201c;Nanotechnology Platform&#x201d; of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We would like to thank Editage (<ext-link ext-link-type="uri" xlink:href="http://www.editage.com">www.editage.com</ext-link>) for English language editing.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmats.2022.877755/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmats.2022.877755/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Gharabli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mavukkandy</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Kujawa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Arafat</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Activation of PVDF Membranes through Facile Hydroxylation of the Polymeric Dope</article-title>. <source>J. Mater. Res.</source> <volume>32</volume> (<issue>22</issue>), <fpage>4219</fpage>&#x2013;<lpage>4231</lpage>. <pub-id pub-id-type="doi">10.1557/jmr.2017.403</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bausch</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>Stasser</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Tonge</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Behavior of Plasma-Treated Elastomeric Polydimethylsiloxane Coatings in Aqueous Environment</article-title>. <source>Plasmas Polym.</source> <volume>3</volume> (<issue>1</issue>), <fpage>23</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1023/a:1022577816591</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betit</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Technical Advances in the Field of ECMO</article-title>. <source>Respir. Care</source> <volume>63</volume> (<issue>9</issue>), <fpage>1162</fpage>&#x2013;<lpage>1173</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.06320</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brook</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Surface Etching of Silicone Elastomers by Depolymerization</article-title>. <source>Can. J. Chem.</source> <volume>90</volume> (<issue>1</issue>), <fpage>153</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1139/v11-145</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruin</surname>
<given-names>G. J. M.</given-names>
</name>
<name>
<surname>Huisden</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kraak</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Poppe</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Performance of Carbohydrate-Modified Fused-Silica Capillaries for the Separation of Proteins by Zone Electrophoresis</article-title>. <source>J. Chromatogr. A</source> <volume>480</volume>, <fpage>339</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9673(01)84303-x</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Somer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fran&#xe7;ois</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van Oeveren</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Poelaert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>De Wolf</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ebels</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Phosphorylcholine Coating of Extracorporeal Circuits Provides Natural protection against Blood Activation by the Material Surface</article-title>. <source>Eur. J. Cardiothorac. Surg.</source> <volume>18</volume> (<issue>5</issue>), <fpage>602</fpage>&#x2013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1016/s1010-7940(00)00508-x</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duy Nguyen</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Nguyen Thi</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Nguyen Thi</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D.-K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Roles of Membrane Technology in Artificial Organs: Current Challenges and Perspectives</article-title>. <source>Membranes</source> <volume>11</volume> (<issue>4</issue>), <fpage>239</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.3390/membranes11040239</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eynden</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Carrier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ouellet</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Demers</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Forcillo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Perrault</surname>
<given-names>L. P.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Avecor Trillium Oxygenator versus Noncoated Monolyth Oxygenator: A Prospective Randomized Controlled Study</article-title>. <source>J. Card. Surg.</source> <volume>23</volume> (<issue>4</issue>), <fpage>288</fpage>&#x2013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8191.2008.00682.x</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Federspiel</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Henchir</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>2004</year>). &#x201c;<article-title>Lung, Artificial: Basic Principles and Current Applications</article-title>,&#x201d; in <source>Encyclopedia of Biomaterials and Biomedical Engineering</source>. Editor <person-group person-group-type="editor">
<name>
<surname>Wnek</surname>
<given-names>G.</given-names>
</name>
</person-group> (<publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC</publisher-name>), <fpage>910</fpage>&#x2013;<lpage>921</lpage>. </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gremmel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Frelinger</surname>
<given-names>A. L.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Michelson</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Platelet Physiology</article-title>. <source>Semin. Thromb. Hemost.</source> <volume>42</volume> (<issue>3</issue>), <fpage>191</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1055/s-0035-1564835</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Surface Monofunctionalized Polymethyl Pentene Hollow Fiber Membranes by Plasma Treatment and Hemocompatibility Modification for Membrane Oxygenators</article-title>. <source>Appl. Surf. Sci.</source> <volume>362</volume>, <fpage>355</fpage>&#x2013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsusc.2015.11.236</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwahashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yuri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nos&#xe9;</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Development of the Oxygenator: Past, Present, and Future</article-title>. <source>J. Artif. Organs</source> <volume>7</volume> (<issue>3</issue>), <fpage>111</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1007/s10047-004-0268-6</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaffer</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Weitz</surname>
<given-names>J. I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The Blood Compatibility Challenge. Part 1: Blood-Contacting Medical Devices: The Scope of the Problem</article-title>. <source>Acta Biomater.</source> <volume>94</volume>, <fpage>2</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2019.06.021</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Braune</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lendlein</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Haemocompatibility Testing of Biomaterials Using Human Platelets</article-title>. <source>Clin. Hemorheol. Microcirc.</source> <volume>53</volume> (<issue>1&#x2013;2</issue>), <fpage>97</fpage>&#x2013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.3233/CH-2012-1579</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kouassi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andji</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bonnet</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Dissolution of Waste Glasses in High Alkaline Solutions</article-title>. <source>J. Ceram.-Silik&#xe1;ty</source> <volume>54</volume> (<issue>3</issue>), <fpage>235</fpage>&#x2013;<lpage>240</lpage>. </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larm</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>A New Non-thrombogenic Surface Prepared by Selective Covalent Binding of Heparin <italic>via</italic> a Modified Reducing Terminal Residue</article-title>. <source>Biomater. Med. Dev. Artif. Organs</source> <volume>11</volume> (<issue>2&#x2013;3</issue>), <fpage>161</fpage>&#x2013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.3109/10731198309118804</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kawahito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>K.-i.</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Linneweber</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Preclinical Evaluation of a Hollow Fiber Silicone Membrane Oxygenator for Extracorporeal Membrane Oxygenator Application</article-title>. <source>ASAIO J.</source> <volume>46</volume> (<issue>4</issue>), <fpage>426</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1097/00002480-200007000-00011</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Maul</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Massicotte</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Wearden</surname>
<given-names>P. D.</given-names>
</name>
</person-group> (<year>2016</year>). &#x201c;<article-title>ECMO Biocompatibility: Surface Coatings, Anticoagulation, and Coagulation Monitoring</article-title>,&#x201d; in <source>Extracorporeal Membrane Oxygenation</source>. Editor <person-group person-group-type="editor">
<name>
<surname>Firstenberg</surname>
<given-names>M.S.</given-names>
</name>
</person-group> (<publisher-name>IntechOpen</publisher-name>), <fpage>27</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.5772/63888</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motomura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawahito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ichikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishitoya</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Development of Silicone Rubber Hollow Fiber Membrane Oxygenator for ECMO</article-title>. <source>Artif. Organs</source> <volume>27</volume> (<issue>11</issue>), <fpage>1050</fpage>&#x2013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1046/j.1525-1594.2003.07077.x</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulvihill</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Faradji</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oberling</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cazenave</surname>
<given-names>J.-P.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Surface Passivation by Human Albumin of Plasmaperesis Circuits Reduces Platelet Accumulation and Thrombus Formation. Experimental and Clinical Studies</article-title>. <source>J. Biomed. Mater. Res.</source> <volume>24</volume> (<issue>2</issue>), <fpage>155</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.820240203</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Teramura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Stable Surface Coating of Silicone Elastomer with Phosphorylcholine and Organosilane Copolymer with Cross-Linking for Repelling Proteins</article-title>. <source>Colloids Surf. B: Biointerfaces</source> <volume>134</volume> (<issue>1</issue>), <fpage>384</fpage>&#x2013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.07.040</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nii</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sueyoshi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Otsuka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Zone Electrophoresis of Proteins in Poly(dimethylsiloxane) (PDMS) Microchip Coated with Physically Adsorbed Amphiphilic Phospholipid Polymer</article-title>. <source>Microfluid. Nanofluid.</source> <volume>14</volume>, <fpage>951</fpage>&#x2013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1007/s10404-012-1102-8</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ontaneda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Annich</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits</article-title>. <source>Front. Med.</source> <volume>5</volume>, <fpage>321</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2018.00321</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfiffer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cormont</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fargin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bousquet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dussauze</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Effects of Deep Wet Etching in HF/HNO<sub>3</sub> and KOH Solutions on the Laser Damage Resistance and Surface Quality of Fused Silica Optics at 351 Nm</article-title>. <source>Opt. Express</source> <volume>25</volume> (<issue>5</issue>), <fpage>4607</fpage>&#x2013;<lpage>4620</lpage>. <pub-id pub-id-type="doi">10.1364/oe.25.004607</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pieri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turla</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Calabr&#xf2;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruggeri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Agracheva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zangrillo</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A New Phosphorylcholine-Coated Polymethylpentene Oxygenator for Extracorporeal Membrane Oxygenation: A Preliminary Experience</article-title>. <source>Perfusion</source> <volume>28</volume> (<issue>2</issue>), <fpage>132</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1177/0267659112469642</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raasveld</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Delnoij</surname>
<given-names>T. S. R.</given-names>
</name>
<name>
<surname>Broman</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Lansink-Hartgring</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Hermans</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>De Troy</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Extracorporeal Membrane Oxygenation in Patients with COVID-19: An International Multicenter Cohort Study</article-title>. <source>J. Intensive Care Med.</source> <volume>36</volume> (<issue>8</issue>), <fpage>910</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1177/08850666211007063</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reser</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dreizler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hasenclever</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Falk</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Retrospective Analysis of Outcome Data with Regards to the Use of Phisio&#xae;-, Bioline&#xae;- or Softline&#xae;-Coated Cardiopulmonary Bypass Circuits in Cardiac Surgery</article-title>. <source>Perfusion</source> <volume>27</volume> (<issue>6</issue>), <fpage>530</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1177/0267659112454558</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanford</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Madathil</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Deatrick</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Tabatabai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Menaker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Galvagno</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Extracorporeal Membrane Oxygenation for COVID-19</article-title>. <source>Innovations (Phila)</source> <volume>15</volume> (<issue>4</issue>), <fpage>306</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1177/1556984520937821</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Shibayama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Quick and Simple Modification of a Poly(dimethylsiloxane) Surface by Optimized Molecular Design of the Anti-biofouling Phospholipid Copolymer</article-title>. <source>Soft Matter</source> <volume>7</volume> (<issue>6</issue>), <fpage>2968</fpage>&#x2013;<lpage>2976</lpage>. <pub-id pub-id-type="doi">10.1039/c0sm01292k</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suhara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oshiyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Efficacy of a New Coating Material, PMEA, for Cardiopulmonary Bypass Circuits in a Porcine Model</article-title>. <source>Ann. Thorac. Surg.</source> <volume>71</volume> (<issue>5</issue>), <fpage>1603</fpage>&#x2013;<lpage>1608</lpage>. <pub-id pub-id-type="doi">10.1016/s0003-4975(01)02466-3</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shiroma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>1981</year>). <article-title>Clinical Performance of Microporous Polypropylene Hollow-Fiber Oxygenator</article-title>. <source>Ann. Thorac. Surg.</source> <volume>32</volume> (<issue>6</issue>), <fpage>558</fpage>&#x2013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1016/s0003-4975(10)61798-5</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Small</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Driver</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>The Use of Rhodamine 6G and Fluorescence Microscopy in the Evaluation of Phospholipid-Based Polymeric Biomaterials</article-title>. <source>J. Microsc.</source> <volume>217</volume> (<issue>3</issue>), <fpage>216</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2818.2005.01453.x</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wendel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ziemer</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Coating-techniques to Improve the Hemocompatibility of Artificial Devices Used for Extracorporeal Circulation</article-title>. <source>Eur. J. Cardiothorac. Surg.</source> <volume>16</volume> (<issue>3</issue>), <fpage>342</fpage>&#x2013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1016/s1010-7940(99)00210-9</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Investigation of KOH Anisotropic Etching for the Fabrication of Sharp Tips in Silicon-On-Insulator (SOI) Material</article-title>. <source>J. Korean Phy. Soc.</source> <volume>37</volume> (<issue>5</issue>), <fpage>605</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.3938/jkps.37.605</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kalulu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>X. K.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Reverse Hydrophobic PDMS Surface to Hydrophilic by 1-Step Hydrolysis Reaction</article-title>. <source>Polym. Adv. Technol.</source> <volume>29</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/pat.4319</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmermann</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Aebert</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ziemer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wendel</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Effect of Biopassive and Bioactive Surface-Coatings on the Hemocompatibility of Membrane Oxygenators</article-title>. <source>J. Biomed. Mater. Res.</source> <volume>80B</volume> (<issue>2</issue>), <fpage>433</fpage>&#x2013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.30614</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zwaal</surname>
<given-names>R. F. A.</given-names>
</name>
<name>
<surname>Hemker</surname>
<given-names>H. C.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Blood Cell Membranes and Haemostasis</article-title>. <source>Pathophysiol. Haemos Thromb.</source> <volume>11</volume> (<issue>1</issue>), <fpage>12</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1159/000214638</pub-id> </citation>
</ref>
</ref-list>
<sec id="s12">
<title>Gloassary</title>
<def-list>
<def-item>
<term id="G1-fmats.2022.877755">
<bold>ACT</bold>
</term>
<def>
<p>activated clotting time</p>
</def>
</def-item>
<def-item>
<term id="G2-fmats.2022.877755">
<bold>AL</bold>
</term>
<def>
<p>artificial lungs</p>
</def>
</def-item>
<def-item>
<term id="G3-fmats.2022.877755">
<bold>APTES</bold>
</term>
<def>
<p>3-aminopropyltrimethoxysilane</p>
</def>
</def-item>
<def-item>
<term id="G4-fmats.2022.877755">
<bold>CAD</bold>
</term>
<def>
<p>computer-aided design</p>
</def>
</def-item>
<def-item>
<term id="G5-fmats.2022.877755">
<bold>CCD</bold>
</term>
<def>
<p>charge-coupled device</p>
</def>
</def-item>
<def-item>
<term id="G6-fmats.2022.877755">
<bold>CFD</bold>
</term>
<def>
<p>computational fluid dynamics</p>
</def>
</def-item>
<def-item>
<term id="G7-fmats.2022.877755">
<bold>cross-MPC copolymer</bold>
</term>
<def>
<p>phosphorylcholine-based copolymer with an organosilane</p>
</def>
</def-item>
<def-item>
<term id="G8-fmats.2022.877755">
<bold>ECMO</bold>
</term>
<def>
<p>extracorporeal membrane oxygenation</p>
</def>
</def-item>
<def-item>
<term id="G9-fmats.2022.877755">
<bold>FITC-BSA</bold>
</term>
<def>
<p>fluorescein isothiocyanate-labeled BSA</p>
</def>
</def-item>
<def-item>
<term id="G10-fmats.2022.877755">
<bold>GA</bold>
</term>
<def>
<p>glutaraldehyde</p>
</def>
</def-item>
<def-item>
<term id="G11-fmats.2022.877755">
<bold>HSA</bold>
</term>
<def>
<p>human serum albumin</p>
</def>
</def-item>
<def-item>
<term id="G12-fmats.2022.877755">
<bold>HFM</bold>
</term>
<def>
<p>hollow fiber membrane</p>
</def>
</def-item>
<def-item>
<term id="G13-fmats.2022.877755">
<bold>HPF</bold>
</term>
<def>
<p>human plasma fibrinogen</p>
</def>
</def-item>
<def-item>
<term id="G14-fmats.2022.877755">
<bold>KOH</bold>
</term>
<def>
<p>potassium hydroxide</p>
</def>
</def-item>
<def-item>
<term id="G15-fmats.2022.877755">
<bold>MPC</bold>
</term>
<def>
<p>2-methacryloyloxyethyl phosphorylcholine</p>
</def>
</def-item>
<def-item>
<term id="G16-fmats.2022.877755">
<bold>MPTMSi</bold>
</term>
<def>
<p>3-methacryloxypropyl trimethoxysilane</p>
</def>
</def-item>
<def-item>
<term id="G17-fmats.2022.877755">
<bold>MPTSSi</bold>
</term>
<def>
<p>3-(methacryloyloxy) propyl-tris(trimethylsilyloxy)silane</p>
</def>
</def-item>
<def-item>
<term id="G18-fmats.2022.877755">
<bold>NaOH</bold>
</term>
<def>
<p>sodium hydroxide</p>
</def>
</def-item>
<def-item>
<term id="G19-fmats.2022.877755">
<bold>OPT</bold>
</term>
<def>
<p>oxygen plasma treatment</p>
</def>
</def-item>
<def-item>
<term id="G20-fmats.2022.877755">
<bold>PC</bold>
</term>
<def>
<p>phosphorylcholine</p>
</def>
</def-item>
<def-item>
<term id="G21-fmats.2022.877755">
<bold>PBS</bold>
</term>
<def>
<p>phosphate-buffered saline</p>
</def>
</def-item>
<def-item>
<term id="G22-fmats.2022.877755">
<bold>PRP</bold>
</term>
<def>
<p>platelet-rich plasma</p>
</def>
</def-item>
<def-item>
<term id="G23-fmats.2022.877755">
<bold>PP</bold>
</term>
<def>
<p>polypropylene</p>
</def>
</def-item>
<def-item>
<term id="G24-fmats.2022.877755">
<bold>PMP</bold>
</term>
<def>
<p>polymethyl pentene</p>
</def>
</def-item>
<def-item>
<term id="G25-fmats.2022.877755">
<bold>R6G</bold>
</term>
<def>
<p>Rhodamine 6G</p>
</def>
</def-item>
<def-item>
<term id="G26-fmats.2022.877755">
<bold>RFI</bold>
</term>
<def>
<p>relative fluorescence intensity</p>
</def>
</def-item>
<def-item>
<term id="G27-fmats.2022.877755">
<bold>SDS</bold>
</term>
<def>
<p>sodium dodecyl sulfate</p>
</def>
</def-item>
<def-item>
<term id="G28-fmats.2022.877755">
<bold>SE</bold>
</term>
<def>
<p>silicone elastomers</p>
</def>
</def-item>
<def-item>
<term id="G29-fmats.2022.877755">
<bold>SEM</bold>
</term>
<def>
<p>scanning electron microscopy</p>
</def>
</def-item>
<def-item>
<term id="G30-fmats.2022.877755">
<bold>WSS</bold>
</term>
<def>
<p>wall shear stress</p>
</def>
</def-item>
<def-item>
<term id="G31-fmats.2022.877755">
<bold>XPS</bold>
</term>
<def>
<p>X-ray photoelectron spectroscopy</p>
</def>
</def-item>
</def-list>
</sec>
</back>
</article>